Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contralateral suppression in adrenal venous sampling predicts clinical and biochemical outcome in primary aldosteronism.
Okubo J, Frudit P, Cavalcante ACBS, Maciel AAW, Freitas TC, Pilan B, Fagundes GFC, Queiroz NL, Stumpf MAM, Souza VCM, Kawahara EZ, Goldbaum TS, Pereira MAA, Calsavara VF, Coelho FMA, Srougi V, Tanno FY, Chambo JL, Bortolotto LA, Drager LF, Fragoso MCBV, Latronico AC, Mendonca BB, Carnevale FC, Almeida MQ. Okubo J, et al. Among authors: calsavara vf. J Clin Endocrinol Metab. 2024 Mar 5:dgae142. doi: 10.1210/clinem/dgae142. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 38442744
Risk of metastasis in BRCA2 carriers diagnosed with triple-negative breast cancer.
Moreno M, Oliveira JS, Brianese RC, de Castro DG, Sanches SM, Torrezan GT, Santiago KM, De Brot M, Cordeiro de Lima VC, Baroni Alves Makdissi F, Casali Da Rocha JC, Calsavara VF, Carraro DM. Moreno M, et al. Among authors: calsavara vf. Cancer Med. 2023 Aug;12(15):16129-16141. doi: 10.1002/cam4.6267. Epub 2023 Jul 23. Cancer Med. 2023. PMID: 37485802 Free PMC article.
Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model.
Pinto FFE, Mello CAL, Nakagawa SA, Chung WT, Torrezan GT, Barros BDF, Cunha IW, Calsavara VF, Carraro DM, Lopes A. Pinto FFE, et al. Among authors: calsavara vf. Clin Orthop Relat Res. 2023 Oct 1;481(10):1978-1989. doi: 10.1097/CORR.0000000000002627. Epub 2023 Apr 27. Clin Orthop Relat Res. 2023. PMID: 37104792
Intraoperative radiotherapy for brain metastases: first-stage results of a single-arm, open-label, phase 2 trial.
de Castro DG, Sanematsu PI Jr, Pellizzon ACA, Suzuki SH, Fogaroli RC, Dias JES Jr, Gondim GRM, Estrada DA, Silva MLG, Rassi MS, Chen MJ, Giacomelli R, Ramos H, Neto ES, Abrahão CH, Coelho TM, Yu LS, de Queiroz Tannous C, Calsavara VF, Giordano FA, de Oliveira JG. de Castro DG, et al. Among authors: calsavara vf. J Neurooncol. 2023 Mar;162(1):211-215. doi: 10.1007/s11060-023-04266-x. Epub 2023 Feb 24. J Neurooncol. 2023. PMID: 36826700 Clinical Trial.
Systemic immune mediators reflect tumour-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast cancer.
Lopes AD, Galdino NAL, Figueiredo AB, Brianese RC, Morais KLP, De Brot M, Osório CABT, Teixeira-Carvalho A, Calsavara VF, Evangelista GFB, Alves NS, Makdissi FB, Sanches SM, Cordeiro de Lima VC, Carraro DM, Gollob KJ. Lopes AD, et al. Among authors: calsavara vf. Immunology. 2023 Jun;169(2):229-241. doi: 10.1111/imm.13627. Epub 2023 Feb 20. Immunology. 2023. PMID: 36703241
64 results